SCHEMBL7746644

SCHEMBL7746644

CC(=O)Nc1oc(-c2ncccc2-c2ccccc2)nc1-c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.62
FLT1 P17948 1/20 0.62
FLT4 P35916 1/20 0.62
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 4/20 0.46
LMNA P02545 1/20 0.46
NR4A2 P43354 1/20 0.46
HPGD P15428 2/20 0.44
S100A4 P26447 2/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
ATR Q13535 1/20 0.41
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
NTRK1 P04629 1/20 0.40
MAPK14 Q16539 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7738998 0.90 KDR (0.57) KDRFLT1FLT4ALDH1A1KDM4E
SCHEMBL7744174 0.89 KDR (0.66) KDRFLT1FLT4ALDH1A1KDM4E
SCHEMBL7744177 0.89 KDR (0.67) KDRFLT1FLT4ALDH1A1KDM4E
SCHEMBL7739021 0.88 KDR (0.67) KDRFLT1FLT4ALDH1A1KDM4E
SCHEMBL7744677 0.87 KDR (0.53) KDRFLT1FLT4ALDH1A1
SCHEMBL7746657 0.86 KDR (0.53) KDRFLT1FLT4ALDH1A1MAPT
SCHEMBL7739009 0.81 KDR (0.77) KDRFLT1FLT4ALDH1A1KDM4E
SCHEMBL7744668 0.76 KDR (0.69) KDRFLT1FLT4ALDH1A1KDM4E
SCHEMBL7746582 0.76 KDR (0.62) KDRFLT1FLT4ALDH1A1KDM4E
SCHEMBL7744663 0.76 KDR (0.76) KDRFLT1FLT4ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed